733049-29-1

Usage

Uses

Used in Pharmaceutical Industry:
(+/-)-1-(carboxymethyl)-3-<(tert-butoxycarbonyl)amino>-2-piperidone is used as a building block for the synthesis of various pharmaceuticals and bioactive molecules. Its versatile structure allows for the creation of a wide range of compounds with potential therapeutic applications.
Used in Enzyme Inhibition:
(+/-)-1-(carboxymethyl)-3-<(tert-butoxycarbonyl)amino>-2-piperidone is used as an inhibitor of enzymes such as phosphodiesterases and proteases. This makes it potentially useful in the development of new drugs for various medical conditions, as enzyme inhibition can play a crucial role in treating a variety of diseases.
Used in Drug Development:
(+/-)-1-(carboxymethyl)-3-<(tert-butoxycarbonyl)amino>-2-piperidone is used in the development of new drugs for various medical conditions. Its potential as an enzyme inhibitor and its versatility as a building block make it a valuable compound for researchers working on the creation of novel therapeutic agents.

Upstream product

• 99707-38-7 (+/-)-1-<(benzyloxycarbonyl)methyl>-3-<(tert-butoxycarbonyl)amino>-2-piperidone 
• 21887-64-9 N^α-(t-butoxycarbonyl)ornithine 
• 99780-98-0 (+/-)-3-<(tert-butoxycarbonyl)amino>-2-piperidone 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1892-22-4 3-aminopiperidin-2-one 

Downstream Products

• 733049-45-1 {1-[(4-amino-benzylcarbamoyl)-methyl]-2-oxo-piperidin-3-yl}-carbamic acid tert-butyl ester 
• 804554-72-1 {1-[(4-guanidino-benzylcarbamoyl)-methyl]-2-oxo-piperidin-3-yl}-carbamic acid tert-butyl ester 
• 733049-47-3 C₃₆H₄₂N₆O₈ 

Relevant academic research and scientific papers

Synthesis and anthelmintic evaluation of novel valerolactam-benzimidazole hybrids

Some novel valerolactam derivatives of 5(6)-substituted-(1H-benzimidazol-2- yl-amine) were constructed based on the union of two structural domains with anthelmintic activity. The tested hybrid compounds 7-9 exhibited greater activity using the Nippostron

ANTIVIRAL COMPOUNDS

The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Conformationally Restricted Inhibitors of Angiotensin Converting Enzyme: Synthesis and Computations

A series of inhibitors of angiotensin converting enzyme (ACE, dipeptidyl carboxypeptidase, EC 3.4.15.1) is described which addresses certain conformational aspects of the enzyme-inhibitor interaction.In this study the alanylproline portion of the potent A

Cyclic hexapeptide

Synthetic novel cyclic hexapeptide having the structure: STR1 and the dipeptide STR2 are prepared. Oral administration of these peptides improves the digestive efficiency of certain herbivorous animals.